M0 Space and The SPARTAN Trial

by | Apr 2018

Eric J. Small, MD, FASCO, presented “M0 Space and The SPARTAN Trial,” followed by a discussion with E. David Crawford, MD. 

How to cite: Small, Eric J. “M0 Space and The SPARTAN Trial” April 18, 2018. Accessed [date today]. https://grandroundsinurology.com/m0-space-and-the-spartan-trial/

M0 Space and The SPARTAN Trial


Eric J. Small, MD, FASCO, defines nonmetastatic castration-resistant prostate cancer, or M0 disease. He then discusses the design, implementation, and results of the SPARTAN trial, which he presented at the 2018 Genitourinary Cancers Symposium. The study tested the efficacy of apalutamide in men with M0 disease.

Following this overview, Dr. Small answers questions from E. David Crawford, MD.